Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2031

Conditions
Mitral Valve Insufficiency
Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Asan Medical Center

OTHER

NCT06757049 - Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population | Biotech Hunter | Biotech Hunter